Cosmo Pharmaceuticals NV
SIX:COPN

Watchlist Manager
Cosmo Pharmaceuticals NV Logo
Cosmo Pharmaceuticals NV
SIX:COPN
Watchlist
Price: 65 CHF Market Closed
Market Cap: 1B CHF
Have any thoughts about
Cosmo Pharmaceuticals NV?
Write Note

Cosmo Pharmaceuticals NV
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cosmo Pharmaceuticals NV
Depreciation & Amortization Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
OVB

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Cosmo Pharmaceuticals NV
SIX:COPN
Depreciation & Amortization
€14.6m
CAGR 3-Years
31%
CAGR 5-Years
24%
CAGR 10-Years
3%
Perrigo Company PLC
NYSE:PRGO
Depreciation & Amortization
$331.5m
CAGR 3-Years
-1%
CAGR 5-Years
-3%
CAGR 10-Years
-3%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Depreciation & Amortization
$650.8m
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
18%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Depreciation & Amortization
$1.6m
CAGR 3-Years
11%
CAGR 5-Years
-20%
CAGR 10-Years
-16%
G
GH Research PLC
NASDAQ:GHRS
Depreciation & Amortization
$315k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ovoca Bio PLC
LSE:OVB
Depreciation & Amortization
€179k
CAGR 3-Years
32%
CAGR 5-Years
32%
CAGR 10-Years
16%

See Also

What is Cosmo Pharmaceuticals NV's Depreciation & Amortization?
Depreciation & Amortization
14.6m EUR

Based on the financial report for Jun 30, 2024, Cosmo Pharmaceuticals NV's Depreciation & Amortization amounts to 14.6m EUR.

What is Cosmo Pharmaceuticals NV's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
3%

Over the last year, the Depreciation & Amortization growth was 5%. The average annual Depreciation & Amortization growth rates for Cosmo Pharmaceuticals NV have been 31% over the past three years , 24% over the past five years , and 3% over the past ten years .

Back to Top